Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Ho

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
Mbio|April 23, 2015
Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillasHannah J Barbian, Julie M Decker, Frederic Bibollet-Ruche, et al.
Cell Reports|October 22, 2020
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular ProbesTongqing Zhou, I-Ting Teng, Adam S Olia, et al.
SSRN|August 4, 2020
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular ProbesTongqing Zhou, I-Ting Teng, Adam S Olia, et al.
Nature Communications|January 4, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerabilityJason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, et al.
Emerging Microbes & Infections|August 5, 2023
SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters<sup>1</sup>Biao Zhou, Runhong Zhou, Jasper Fuk-Woo Chan, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman PrimatesMichael G Joyce, Hannah A D King, Ines Elakhal Naouar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Lakhal-Naouar, et al.
Science Translational Medicine|December 16, 2021
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primatesM Gordon Joyce, Hannah A D King, Ines Elakhal-Naouar, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Elakhal Naouar, et al.
Science (New York, N.Y.)|September 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studyKathryn M Hastie, Haoyang Li, Daniel Bedinger, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Mbio|April 23, 2015
Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillasHannah J Barbian, Julie M Decker, Frederic Bibollet-Ruche, et al.
Cell Reports|October 22, 2020
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular ProbesTongqing Zhou, I-Ting Teng, Adam S Olia, et al.
SSRN|August 4, 2020
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular ProbesTongqing Zhou, I-Ting Teng, Adam S Olia, et al.
Nature Communications|January 4, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerabilityJason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, et al.
Emerging Microbes & Infections|August 5, 2023
SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters<sup>1</sup>Biao Zhou, Runhong Zhou, Jasper Fuk-Woo Chan, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman PrimatesMichael G Joyce, Hannah A D King, Ines Elakhal Naouar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Lakhal-Naouar, et al.
Science Translational Medicine|December 16, 2021
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primatesM Gordon Joyce, Hannah A D King, Ines Elakhal-Naouar, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Elakhal Naouar, et al.
Science (New York, N.Y.)|September 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studyKathryn M Hastie, Haoyang Li, Daniel Bedinger, et al.
Pageof 25